Entry
Name
Pertussis
Description
Pertussis, also known as whooping cough, is an acute respiratory infectious disease caused by a bacteria called Bordetella Pertussis. The characteristic symptoms are paroxysmal cough, inspiratory wheezing and post-tussive vomiting.
Following the inhalation of respiratory secretions from an infected individual, bacteria enter the upper respiratory tract and adhere to epithelial cells. Several adhesion factors have been implicated: the filamentous hemagglutinin (FHA), fimbriae, and pertactin (Prn).
Pertussis toxin (Ptx) and adenylate cyclase toxin (ACT) have been identified so far as major protein toxins of B. pertussis. PTX is a hexameric AB5-type exotoxin. Catalytic A subunit catalyzes the ADP-ribosylation of the Gi subunits of the heterotrimeric G protein, then inhibits multiple downstream pathways. ACT is able to penetrate the cytoplasmic membrane of host cells and becomes activated through the cleavage and the binding of calmodulin (CaM). Activated ACT converts ATP to cyclic AMP and subverts cellular signaling pathways.
Class
Human Diseases; Infectious disease: bacterial
BRITE hierarchy
Pathway map
Module
M00574 Pertussis pathogenicity signature, pertussis toxin [PATH:ko05133 ]
Disease
Orthology
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K03156 TNF, TNFA; tumor necrosis factor superfamily, member 2
K03986 C1QA; complement C1q subcomponent subunit A
K03987 C1QB; complement C1q subcomponent subunit B
K03988 C1QG; complement C1q subcomponent subunit C
K03989 C4; complement component 4
K03990 C3; complement component 3
K03994 C5; complement component 5
K04001 SERPING1, C1INH; C1 inhibitor
K04002 C4BPA; complement component 4 binding protein alpha
K04003 C4BPB; complement component 4 binding protein beta
K04379 FOS; proto-oncogene protein c-fos
K04383 IL1A; interleukin 1 alpha
K04391 CD14; monocyte differentiation antigen CD14
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24 ]
K04448 JUN; transcription factor AP-1
K04513 RHOA; Ras homolog gene family, member A
K04519 IL1B; interleukin 1 beta
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04729 MYD88; myeloid differentiation primary response protein MyD88
K04730 IRAK1; interleukin-1 receptor-associated kinase 1 [EC:2.7.11.1 ]
K04733 IRAK4; interleukin-1 receptor-associated kinase 4 [EC:2.7.11.1 ]
K04735 RELA; transcription factor p65
K05400 LY96, MD-2; lymphocyte antigen 96
K05403 TIRAP; toll-interleukin 1 receptor (TIR) domain-containing adaptor protein
K05409 TIRP, TRAM; TRIF-related adaptor molecule
K05411 IRF3; interferon regulatory factor 3
K05426 IL23A; interleukin 23 subunit alpha
K05443 IL10, CSIF; interleukin 10
K05506 CXCL5_6, SCYB5_6; C-X-C motif chemokine 5/6
K05719 ITGB1, CD29; integrin beta 1
K05842 TRIF; toll-like receptor adapter molecule 1
K06461 ITGAM, CD11b; integrin alpha M
K06464 ITGB2, CD18; integrin beta 2
K06484 ITGA5, CD49e; integrin alpha 5
K07326 fhaC; hemolysin activation/secretion protein
K07345 fimA; major type 1 subunit fimbrin (pilin)
K07347 fimD, fimC, mrkC, htrE, cssD; outer membrane usher protein
K07389 cyaC, hlyC, rtxC; cytolysin-activating lysine-acyltransferase [EC:2.3.1.-]
K07679 evgS, bvgS; two-component system, NarL family, sensor histidine kinase EvgS [EC:2.7.13.3 ]
K07690 evgA, bvgA; two-component system, NarL family, response regulator EvgA
K08727 NOD1, CARD4; nucleotide-binding oligomerization domain-containing protein 1
K09444 IRF1; interferon regulatory factor 1
K10030 IL8, CXCL8; interleukin 8
K10067 SFTPA; pulmonary surfactant-associated protein A
K10155 IRF8; interferon regulatory factor 8
K10160 TLR4, CD284; toll-like receptor 4
K11003 hlyD, cyaD; membrane fusion protein, hemolysin D
K11004 hlyB, cyaB; ATP-binding cassette, subfamily B, bacterial HlyB/CyaB
K11023 ptxA, artA, pltA; pertussis toxin subunit 1 [EC:2.4.2.-]
K11024 ptxB; pertussis toxin subunit 2
K11025 ptxC; pertussis toxin subunit 3
K11026 ptxD; pertussis toxin subunit 4
K11027 ptxE; pertussis toxin subunit 5
K12340 tolC, bepC, cyaE, raxC, sapF, rsaF, hasF; outer membrane protein
K12683 brkA; serum resistance protein
K12688 sphB1, nalP, ausP; autotransporter serine protease [EC:3.4.21.-]
K12799 PYCARD, ASC; apoptosis-associated speck-like protein containing a CARD
K12800 NLRP3, PYPAF1; NACHT, LRR and PYD domains-containing protein 3
K15125 fhaB; filamentous hemagglutinin
K15126 bteA; type III secretion system cytotoxic effector protein
K22944 cyaA; bifunctional hemolysin/adenylate cyclase
Compound
Reference
Authors
de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR
Title
Pertussis: a matter of immune modulation.
Journal
Reference
Authors
Carbonetti NH
Title
Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.
Journal
Reference
Authors
van den Berg BM, van Furth R, Hazenbos WL
Title
Activation of complement receptor 3 on human monocytes by cross-linking of very-late antigen-5 is mediated via protein tyrosine kinases.
Journal
Reference
Authors
Mazar J, Cotter PA
Title
Topology and maturation of filamentous haemagglutinin suggest a new model for two-partner secretion.
Journal
Reference
Authors
Hewlett EL, Donato GM, Gray MC
Title
Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP!
Journal
Reference
Authors
Dunne A, Ross PJ, Pospisilova E, Masin J, Meaney A, Sutton CE, Iwakura Y, Tschopp J, Sebo P, Mills KH
Title
Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis.
Journal
Reference
Authors
Hickey FB, Brereton CF, Mills KH
Title
Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.
Journal
Reference
Authors
Spensieri F, Fedele G, Fazio C, Nasso M, Stefanelli P, Mastrantonio P, Ausiello CM
Title
Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction.
Journal
Reference
Authors
Fiser R, Masin J, Basler M, Krusek J, Spulakova V, Konopasek I, Sebo P
Title
Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b+ monocytes independently of the catalytic and hemolytic activities.
Journal
Reference
Authors
Wang ZY, Yang D, Chen Q, Leifer CA, Segal DM, Su SB, Caspi RR, Howard ZO, Oppenheim JJ
Title
Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways.
Journal
Reference
Authors
Fan H, Peck OM, Tempel GE, Halushka PV, Cook JA
Title
Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation.
Journal
Reference
Authors
Lee MS, Kim YJ
Title
Signaling pathways downstream of pattern-recognition receptors and their cross talk.
Journal
Reference
Authors
Kawai T, Akira S
Title
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.
Journal
Reference
Authors
Ferlito M, Romanenko OG, Guyton K, Ashton S, Squadrito F, Halushka PV, Cook JA
Title
Implication of Galpha i proteins and Src tyrosine kinases in endotoxin-induced signal transduction events and mediator production.
Journal
J Endotoxin Res 8:427-35 (2002)
Reference
Authors
Han HJ, Kuwae A, Abe A, Arakawa Y, Kamachi K
Title
Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis.
Journal
Reference
Authors
Beier D, Gross R
Title
Regulation of bacterial virulence by two-component systems.
Journal
Reference
Authors
Cotter PA, Jones AM
Title
Phosphorelay control of virulence gene expression in Bordetella.
Journal
Related pathway
ko04610 Complement and coagulation cascades
ko04620 Toll-like receptor signaling pathway